Fluence Corporation Inked Partnership Agreement With ITEST – A Quick Look

On December 20, 2018, Fluence Corporation (ASX: FLC) has made an announcement related to the contracts which the company has entered with regards to the partnership agreement with ITEST. As per the press release which was issued, the company had secured two contracts and, as a result of which, it would be supplying Aspiral™ Smart Packaged wastewater treatment plants. Following the initial contracts which have been discussed, the company would be supplying Aspiral™ Smart Packaged wastewater treatment plants to the thirteen sites. As per the press release, there are expectations that there would be 35 Aspiral™ units which would be put to use so that varied capacity requirements can be seen with regards to individual sites. Out of the total 35 Aspiral™ units which have been discussed, five would be of S1 models while thirty would be of L4 models. The company had also stated that it would be S1 type’s first sale.[optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

In the month of October 2018, the company had made an announcement regarding the partnership with ITEST. ITEST has plans to apply Aspiral™ wastewater treatment solutions with regards to the Highway Service Centres which are located in the Hubei Province. Let us see what the management of the company has to say. The top management of the company reflected favorable views with regards to the orders. As per the management, the orders which the company has managed to secure happens to be a strong start.

Recently, the company had also made an announcement that it had managed to wrap up its share purchase plan which also witnessed the help from the shareholders. As a result of the share purchase plan, the company had raised $3.3 million. This capital has garnered the capital from 393 eligible shareholders. In the press release, the company had also stated the areas in which it plans to deploy this capital. The amount which has been garnered as a result of latest share placement as well as the share purchase plan amounting to $36.5 million are supportive to the FLC’s growth plans as it would be used for working capital purposes so that the growth prospects in the business with regards to China can be financed and it would be utilized for the business’ general working capital. These funds would also be used for equity part with respect to Build Own and Operate projects. The top management of the company had stated favorable views with regards to support which has been extended by the shareholders (retail). Earlier, the company had released its quarterly report which covers data for the cash flows. In the September 2018 quarter, Fluence Corporation’s net cash which got used in the operating activities was US$12.9 million.

We will now see how FLC’s stock has performed in the past few months. The stock price is currently trading at A$0.335 per share with the market capitalization of around $177 million. Over the past six months, Fluence Corporation has delivered the return of -29.03%. However, in the previous three months, the stock posted -19.51% return.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report